The Food and Drug Monitoring Agency (BPOM) has authorized phase 3 clinical trials of the M72 tuberculosis (TB) vaccine in ...

Bacille Calmette-Guérin (BCG) revaccination is not efficacious for preventing sustained Mycobacterium tuberculosis infection, ...

The bacillus Calmette–Guérin (BCG) vaccine, initially developed to provide protection against TB, also protects against leprosy; and the magnitude of this effect varies. Previous meta-analyses ...

A prior phase II trial had shown that BCG revaccination in teens led to 45.4% efficacy in reversion from positive to negative ...

BCG (Bacillus Calmette - Guerin) vaccine is made from a treated (attenuated) live strain of bacterium derived from Mycobacterium bovis, a bacterium which typically causes tuberculosis (TB ...

The head of Pasteur Institute of Iran (PII) announced the export of more than 700,000 doses of the BCG vaccine to the ...

Millions of children due for vaccination will have to wait for another month, with the Ministry of Health now saying the ...

Academic researchers in Massachusetts believe the standard BCG (bacillus Calmette-Guérin) vaccine could have a remarkable second use: a treatment to reverse advanced type 1 diabetes. The cause of ...

Lactate, a product of scaled-up energy production, appears to play a key role in inducing trained immunity after vaccines.

The immune system can work in two ways: the innate immune system reacts to any foreign invaders that are identified by immune cells that look... | Cell And Molecular Biology ...